Holen Sie sich die Stockscreener-App
146.68
1.00%
1.45
Handel nachbörslich:
146.68
Schlusskurs vom Vortag:
$145.23
Offen:
$146.85
24-Stunden-Volumen:
353.33K
Relative Volume:
0.75
Marktkapitalisierung:
$4.49B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-30.18
EPS:
-4.86
Netto-Cashflow:
$-87.43M
1W Leistung:
+4.40%
1M Leistung:
+8.51%
6M Leistung:
+72.20%
1J Leistung:
+49.90%
1-Tages-Spanne:
$145.05
$147.46
1-Wochen-Bereich:
$138.18
$147.46
52-Wochen-Spanne:
$55.92
$147.46
Irhythm Technologies Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Technologies Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
146.68 | 4.49B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
Patent Office Leader Rejects IPRs Based On 12-Year Wait - Law360
iRhythm Technologies stock hits 52-week high at $147 By Investing.com - Investing.com South Africa
iRhythm Technologies stock hits 52-week high at $147 - Investing.com India
Should You Hold iRhythm Technologies (IRTC)? - Insider Monkey
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
U.S. Smart Wearable ECG Monitors Market Size Report 2030 - Grand View Research
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks - Yahoo Finance
iRhythm at 45th Annual William Blair Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Heart Device Maker iRhythm Gets Investor Claims Trimmed - Law360
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
iRhythm Fails to Snuff Investor Suit Over Heart Monitor Flaws - Bloomberg Law News
Healthcare Tech And Innovation: Heart Monitors Improving - Seeking Alpha
iRhythm Technologies Inc (IRTC) Stock Price Up 3.75% on Jun 3 - GuruFocus
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class ActionIRTC - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Smart Wearable ECG Monitors Market Size Report, 2030 - Grand View Research
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC) - ACCESS Newswire
(IRTC) Trading Signals - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation - ACCESS Newswire
iRhythm Technologies Holds 2025 Annual Stockholders Meeting - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out - ACCESS Newswire
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Nuveen Asset Management LLC - Defense World
Millennium Management LLC Reduces Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
BNP Paribas Financial Markets Sells 7,391 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
(IRTC) Technical Data - news.stocktradersdaily.com
PRE Soars Over 70% In Just Three Days, VIGL Snapped Up, IRTC Finds Its Rhythm Again... - Nasdaq
Ameriprise Financial Inc. Buys 8,528 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
Demystifying iRhythm Technologies: Insights From 6 Analyst Reviews - Benzinga
iRhythm Technologies (IRTC) Sees Price Target Hiked by Citigroup - GuruFocus
iRhythm Technologies (IRTC) Sees Price Target Hiked by Citigroup | IRTC Stock News - GuruFocus
iRhythm (IRTC) Price Target Lifted by Citi Analyst to $167 | IRT - GuruFocus
iRhythm Technologies to Participate in Upcoming Investor Conferences - The Manila Times
iRhythm Technologies to Participate in Upcoming Investor Conferences | IRTC Stock News - GuruFocus
iRhythm Technologies, Inc. to Present at Multiple Investor Conferences in June 2025 - Nasdaq
iRhythm Stock Hits 52-Week High at $142.69 Amid Growth Surge - Investing.com Australia
IRTC SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Brokerages Set iRhythm Technologies, Inc. (NASDAQ:IRTC) PT at $128.55 - MarketBeat
3 Overrated Stocks Facing Headwinds - Yahoo Finance
iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Average Rating of “Moderate Buy” by Analysts - Defense World
IRTC Q1 Earnings Call: Outperformance Driven by Zio AT and Primary Care Channel Expansion - Yahoo Finance
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? - TradingView
Cardiac Event Monitor Market Expanding Due to Rising Cardiac - openPR.com
iRhythm Technologies, Inc. (NASDAQ:IRTC): Is Breakeven Near? - simplywall.st
2 Healthcare Stocks to Keep an Eye On and 1 to Ignore - Yahoo Finance
Transcript : IRhythm Technologies, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03 - marketscreener.com
iRhythm at Bank of America Conference: Strategic Growth and Challenges By Investing.com - Investing.com India
iRhythm at Bank of America Conference: Strategic Growth and Challenges - Investing.com
Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now - Insider Monkey
UPCOMING IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
11 Best Performing Healthcare Stocks to Buy Now - Insider Monkey
iRhythm Technologies, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights – IRTC - ACCESS Newswire
Finanzdaten der Irhythm Technologies Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Irhythm Technologies Inc-Aktie (IRTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rosenbaum Marc W. | Chief Accounting Officer |
Jun 02 '25 |
Sale |
140.21 |
696 |
97,586 |
11,105 |
| Wilson Daniel G. | Chief Financial Officer |
May 02 '25 |
Sale |
125.00 |
2,000 |
250,000 |
43,307 |
| Patterson Chad | Chief Commercial Officer |
May 02 '25 |
Sale |
120.55 |
8,510 |
1,025,898 |
49,930 |
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):